These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10961068)

  • 21. Vascular permeability of the middle ear mucosa in otitis media with effusion.
    Hamaguchi Y; Juhn SK
    Arch Otorhinolaryngol; 1987; 244(4):218-21. PubMed ID: 3689200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of ceftazidime into middle ear fluid in children with otitis media with effusion.
    Bégué P; Garabédian EN; Bertrand C; Aubert B; Chiche D
    Laryngoscope; 1998 May; 108(5):662-4. PubMed ID: 9591542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant in middle ear effusions.
    Grace A; Kwok P; Hawke M
    Otolaryngol Head Neck Surg; 1987 Apr; 96(4):336-40. PubMed ID: 3108821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphologic and biochemical study of vascular permeability of the middle ear mucosa in experimental otitis media.
    Sakagami M; Harada T; Juhn SK; Duvall AJ
    Ann Otol Rhinol Laryngol; 1990 Aug; 99(8):654-9. PubMed ID: 1696441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult-onset fluid in the tympanomastoid compartment. Diagnosis and management.
    Schuknecht HF; Zaytoun GM; Moon CN
    Arch Otolaryngol; 1982 Dec; 108(12):759-65. PubMed ID: 6890798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of immunoglobulins, the complement system and inflammatory mediators with reference to the pathogenesis of serous otitis media].
    Jeep S
    Laryngorhinootologie; 1990 Apr; 69(4):201-7. PubMed ID: 2354013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The expression and clinical significance of pepsin and pepsinogen in patients with otitis media with effusion].
    Luo H; Gao Y; Ma S; Yang Q; Shao N; Zhang A; Xu M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jul; 29(14):1252-5. PubMed ID: 26672236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of protease inhibitors in the pathogenesis of otitis media with effusion.
    Hamaguchi Y; Majima Y; Ukai K; Sakakura Y; Miyoshi Y
    Auris Nasus Larynx; 1985; 12 Suppl 1():S145-7. PubMed ID: 3835890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic aspects of otitis media with effusion.
    Mogi G; Watanabe N; Maeda S; Umehara T
    Acta Otorhinolaryngol Belg; 1983; 37(1):5-21. PubMed ID: 6351530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research on the relationship of IgE between adenoid and middle ear effusion in children otitis media with effusion cases].
    Feng X; Deng H; Wang J; Xiao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 25(13):588-9. PubMed ID: 21949988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic penetration into the otorhinolaryngologic system in children. II. Concentration of cefotaxime in the middle ear].
    Bégué P; Léowski S; Safran C; Nocquet N; Bodard M; Cotin G
    Ann Otolaryngol Chir Cervicofac; 1983; 100(4):243-5. PubMed ID: 6309057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental otitis media with effusion induced by middle ear effusion.
    Nakata J; Suzuki M; Kawauchi H; Mogi G
    Laryngoscope; 1992 Sep; 102(9):1037-42. PubMed ID: 1518349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium levels in middle ear fluids and sera in otitis media with effusion.
    Yue WL; Xu ZH; Fu YL; Ye QZ; Luo JY
    Eur Arch Otorhinolaryngol; 1992; 249(4):209-10. PubMed ID: 1642878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease inhibitors in middle ear effusions.
    Carlsson B; Lundberg C; Ohlsson K
    Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):38-41. PubMed ID: 6162410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion.
    Harrison CJ; Chartrand SA; Rodriguez W; Schwartz R; Pollack J; Thedinger B; Block SL; Hedrick JA
    Pediatr Infect Dis J; 1997 Aug; 16(8):816-7. PubMed ID: 9271047
    [No Abstract]   [Full Text] [Related]  

  • 36. PO2 levels in middle ear effusions and middle ear mucosa.
    Takahashi M; Niwa H; Yanagita N
    Acta Otolaryngol Suppl; 1990; 471():39-42. PubMed ID: 2239244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol content in middle ear fluid in secretory otitis media.
    Palva T; Helin A
    Acta Otolaryngol; 1986; 101(5-6):442-4. PubMed ID: 3727979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the correlation of substance P in middle ear effusion and clinical presentation in secretory otitis media].
    Wang Gf
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Nov; 19(22):1026-8. PubMed ID: 16463765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-gamma in suppurative otitis media: significance of otorrhoea type and disease outcome.
    Lasisi AO; Olayemi O; Arinola OG; Omilabu SA
    J Laryngol Otol; 2009 Oct; 123(10):1103-7. PubMed ID: 19640314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-standing otitis media with effusion--a convenient model for the study of antibiotic penetration to respiratory tract secretions.
    Edén T
    Scand J Infect Dis Suppl; 1985; 44():46-51. PubMed ID: 3860937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.